SADDAN syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 9-10, 2011, Pages 851-852

  Hari Kumar, K V S ^a   Shaikh, Altamash ^b   Sharma, Ruchita ^a   Prusty, Pitamber ^a  

^a Department of Laboratory Medicine and Transfusion Medicine   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Acanthosis nigricans; Achondroplasia; Skeletal dysplasia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH HORMONE;

ACANTHOSIS NIGRICANS; ACHONDROPLASIA; ANTHROPOMETRY; ARTICLE; BONE DYSPLASIA; CASE REPORT; CHILD; CRANIOFACIAL SYNOSTOSIS; FRONTAL BOSSING; GENE MUTATION; GROWTH RETARDATION; HEAD CIRCUMFERENCE; HORMONAL THERAPY; HUMAN; LANGUAGE DEVELOPMENT; MALE; NOSE SEPTUM; PRESCHOOL CHILD; RHIZOMELIA; SADDAN SYNDROME; SHORT STATURE; SPEECH DEVELOPMENT; TWINS; VITAMIN SUPPLEMENTATION;

ACHONDROPLASIA; CHILD, PRESCHOOL; DISEASES IN TWINS; HUMANS; MALE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIBLINGS; TWINS;

EID: 80054060660     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.290     Document Type: Article

References (3)

1. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000;21:23-39. (Pubitemid 32260394)
2. Bellus GA, Bamshad MJ, Przylepa K, Dorst J, Lee RR, et al. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by the fibroblast growth factor receptor 3 Lys650Met mutation. Am J Med Genet 1999;85:53-65. (Pubitemid 29256805)
3. Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol 2002;147:1096-101. (Pubitemid 36963014)